Nevro Non Current Assets Total from 2010 to 2025

NVRO Stock  USD 5.71  0.01  0.17%   
Nevro Corp Non Current Assets Total yearly trend continues to be very stable with very little volatility. Non Current Assets Total are likely to grow to about 126.5 M this year. Non Current Assets Total is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. View All Fundamentals
 
Non Current Assets Total  
First Reported
2013-12-31
Previous Quarter
117.1 M
Current Value
116.4 M
Quarterly Volatility
29.9 M
 
Yuan Drop
 
Covid
Check Nevro Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nevro Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 13.9 M, Interest Expense of 8.8 M or Selling General Administrative of 215.3 M, as well as many indicators such as Price To Sales Ratio of 1.99, Dividend Yield of 0.0 or PTB Ratio of 2.26. Nevro financial statements analysis is a perfect complement when working with Nevro Corp Valuation or Volatility modules.
  
Check out the analysis of Nevro Corp Correlation against competitors.
To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.

Latest Nevro Corp's Non Current Assets Total Growth Pattern

Below is the plot of the Non Current Assets Total of Nevro Corp over the last few years. It is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. Nevro Corp's Non Current Assets Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nevro Corp's overall financial position and show how it may be relating to other accounts over time.
Non Current Assets Total10 Years Trend
Slightly volatile
   Non Current Assets Total   
       Timeline  

Nevro Non Current Assets Total Regression Statistics

Arithmetic Mean35,776,196
Geometric Mean9,096,152
Coefficient Of Variation122.43
Mean Deviation33,516,471
Median19,257,000
Standard Deviation43,799,221
Sample Variance1918.4T
Range126.2M
R-Value0.88
Mean Square Error462.9T
R-Squared0.77
Slope8,097,811
Total Sum of Squares28775.6T

Nevro Non Current Assets Total History

2025126.5 M
2024120.5 M
2023104.8 M
202239.5 M
202143.3 M
202036.3 M
201947.6 M

About Nevro Corp Financial Statements

Nevro Corp investors utilize fundamental indicators, such as Non Current Assets Total, to predict how Nevro Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Non Current Assets Total120.5 M126.5 M
When determining whether Nevro Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nevro Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nevro Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nevro Corp Stock:
Check out the analysis of Nevro Corp Correlation against competitors.
To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nevro Corp. If investors know Nevro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nevro Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.87)
Revenue Per Share
11.404
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.09)
Return On Equity
(0.25)
The market value of Nevro Corp is measured differently than its book value, which is the value of Nevro that is recorded on the company's balance sheet. Investors also form their own opinion of Nevro Corp's value that differs from its market value or its book value, called intrinsic value, which is Nevro Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nevro Corp's market value can be influenced by many factors that don't directly affect Nevro Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nevro Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nevro Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nevro Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.